ConductScience.org, home

Paper30723593

Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.

Yaddanapudi K and 7 others. Oncoimmunology, 2019. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention. Papers, record 30723593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30723593

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.
PubMed
Journal
Oncoimmunology
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2021-01-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yaddanapudi KKavitha
2Meng SShuhan
3Whitt AGAaron G
4Al Rayyan NNuman
5Richie JJamaal
6Tu AAllison
7Eaton JWJohn W
8Li CChi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01 CA106599NCI NIH HHSUnited StatesK01CA106599PubMed and NIHNIH RePORTER
P20 RR018733NCRR NIH HHSUnited StatesP20RR018733PubMedNIH RePORTER
R01 AA018016NIAAA NIH HHSUnited StatesR01AA018016PubMed and NIHNIH RePORTER
P30 GM106396NIGMS NIH HHSUnited StatesP30GM106396PubMed and NIHNIH RePORTER
R21 CA198249NCI NIH HHSUnited StatesR21CA198249PubMed and NIHNIH RePORTER
R01 CA175003NCI NIH HHSUnited StatesR01CA175003PubMed and NIHNIH RePORTER

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110545503Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.J Cell Biol1999https://conductscience.org/library/papers/10545503PubMed
211897870Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.Stem Cells2002https://conductscience.org/library/papers/11897870PubMed
311900993GM-CSF-based cellular vaccines: a review of the clinical experience.Cytokine Growth Factor Rev2002https://conductscience.org/library/papers/11900993PubMed
412154376Exosomes: composition, biogenesis and function.Nat Rev Immunol2002https://conductscience.org/library/papers/12154376PubMed
512445288GM-CSF-based cancer vaccines.Immunol Rev2002https://conductscience.org/library/papers/12445288PubMed
612771702Tumor markers in the diagnosis of primary bladder cancer. A systematic review.J Urol2003https://conductscience.org/library/papers/12771702PubMed
712947071
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
J Clin Oncol2003https://conductscience.org/library/papers/12947071PubMed
814595124Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation.Stem Cells2003https://conductscience.org/library/papers/14595124PubMed
916557261Regulatory T cells, tumour immunity and immunotherapy.Nat Rev Immunol2006https://conductscience.org/library/papers/16557261PubMed
1016796806Prospects for exosomes in immunotherapy of cancer.J Cell Mol Med2006https://conductscience.org/library/papers/16796806PubMed
1116860657Cancer vaccines: preclinical studies and novel strategies.Adv Cancer Res2006https://conductscience.org/library/papers/16860657PubMed
1217486113Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat Cell Biol2007https://conductscience.org/library/papers/17486113PubMed
1317577033Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.J Clin Oncol2007https://conductscience.org/library/papers/17577033PubMed
1418375791Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.Blood2008https://conductscience.org/library/papers/18375791PubMed
1518443585An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.Nat Genet2008https://conductscience.org/library/papers/18443585PubMed
1619171137Embryonic vaccines against cancer: an early history.Exp Mol Pathol2009https://conductscience.org/library/papers/19171137PubMed
1719319200Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.PLoS One2009https://conductscience.org/library/papers/19319200PubMed
1819816950Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer.Stem Cells2009https://conductscience.org/library/papers/19816950PubMed
1919898981GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.Breast Cancer Res Treat2010https://conductscience.org/library/papers/19898981PubMed
2020512124An autoimmune-mediated strategy for prophylactic breast cancer vaccination.Nat Med2010https://conductscience.org/library/papers/20512124PubMed

See all 50 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
41843206Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges.J Cancer Res Clin Oncol2026https://conductscience.org/library/papers/41843206PubMed
41809263Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress.Asian J Pharm Sci2025https://conductscience.org/library/papers/41809263PubMed
41256221Bioengineered Extracellular Vesicles in Emerging Cancer Vaccine Platforms.Small Sci2025https://conductscience.org/library/papers/41256221PubMed
41131419Biomedical applications of extracellular vesicles (EVs): even better with cryogels.Mikrochim Acta2025https://conductscience.org/library/papers/41131419PubMed
40843170Engineered exosomes: a promising design platform for overcoming cancer therapy resistance.Front Cell Dev Biol2025https://conductscience.org/library/papers/40843170PubMed
40532508Biodistribution studies of 89Zr-Labeled stem cell-derived exosomes using PET imaging.Appl Radiat Isot2025https://conductscience.org/library/papers/40532508PubMed
40475972Engineered extracellular vesicles derived from pluripotent stem cells: a cell-free approach to regenerative medicine.Burns Trauma2025https://conductscience.org/library/papers/40475972PubMed
40160248Engineered extracellular vesicles as imaging biomarkers and therapeutic applications for urological diseases.Mater Today Bio2025https://conductscience.org/library/papers/40160248PubMed
39739089The efficacy of an embryonic stem cell-based vaccine for lung cancer prevention depends on the undifferentiated state of the stem cells.Sci Rep2024https://conductscience.org/library/papers/39739089PubMed
39591185Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application.Vaccines (Basel)2024https://conductscience.org/library/papers/39591185PubMed
39483807Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics.J Extracell Biol2024https://conductscience.org/library/papers/39483807PubMed
39040921Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy.Research (Wash D C)2024https://conductscience.org/library/papers/39040921PubMed
38098229Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunity.Mol Ther2024https://conductscience.org/library/papers/38098229PubMed
37365450The therapeutic potential of exosomes in lung cancer.Cell Oncol (Dordr)2023https://conductscience.org/library/papers/37365450PubMed
37048091Frontier Review of the Molecular Mechanisms and Current Approaches of Stem Cell-Derived Exosomes.Cells2023https://conductscience.org/library/papers/37048091PubMed
36860847Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells.Front Immunol2023https://conductscience.org/library/papers/36860847PubMed
36742283Exosome-based cancer vaccine for prevention of lung cancer.Stem Cell Investig2023https://conductscience.org/library/papers/36742283PubMed
36727049Exosomes and cancer immunotherapy: A review of recent cancer research.Front Oncol2022https://conductscience.org/library/papers/36727049PubMed
35915054Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.Drug Deliv2022https://conductscience.org/library/papers/35915054PubMed
34842232Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells.J Vis Exp2021https://conductscience.org/library/papers/34842232PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30723593

GET https://conductscience.org/api/papers/v1/30723593/references?page=2